4
Changes in Ownership
Intellia Therapeutics, Inc. Filed Acc 0000950170-25-001237
EVP, Chief Medical Officer acquired 3,189 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lebwohl David EVP, Chief Medical Officer | 2025-01-01 | Option exercise | +3,189 | 97,223 | D | ||
| Derivatives | |||||||
| Lebwohl David EVP, Chief Medical Officer | 2025-01-01 | Option exercise · Restricted Stock Unit | −3,189 | 0 | D | ||
Loading xslF345X05/ownership.xml…